India Remdesivir Supply Gap May Normalize Soon, But No End To Greed
Gilead Licensees Moving To Improve Supplies
India generic remdesivir supply situation seen improving soon, with existing players Cipla and Hetero ramping up the antiviral and the arrival of new entrant Mylan. But will that be enough to control black marketing of the investigational COVID-19 therapy? The government is also keeping a close watch on the goings on.
